BRIEF-Bristol-Myers sees restructuring charges between $1.5-$2.0 bln through 2020
February 21, 2017 at 12:23 PM EST
* Bristol-Myers Squibb says expects to incur charges through 2020, ranging between $1.5 billion to $2.0 billion in connection with restructuring announced in Oct 2016
